.jpg?itok=LooO274g)
Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Understanding how tumors respond to radiation has been a lifelong process for Puneeth Iyengar, M.D., Ph.D., Assistant Professor of Radiation Oncology at UT Southwestern Medical Center. He began testing theories in school science fairs as an adolescent growing up in Louisiana. Studying at MIT furthered his interest in the biologic and engineering aspects of medicine, and he earned a bachelor of science degree in biology before receiving his M.D./Ph.D. degrees from Albert Einstein College of Medicine in New York in 2005.
Lung Cancer Video Library 2025
As part of the 2025 Lung Cancer Video Library, where oncologists discuss the most emerging treatment options and informatIon in lung cancer, Dr. Puneeth Iyengar (Memorial Sloan Kettering Cancer Center) discusses when to consider radiation and/or surgery in the management of advanced non-small cell lung cancer (NSCLC) for survival benefit.
Image
 (published in) 2025 series title slide.jpg)
In these video series, Dr. Iyengar discusses two indications, or timepoints, where radiation and/or surgery may be used to improve the survival outcomes in metastatic, non-small cell lung cancer (NSCLC) patients, specifically focusing on consolidation. He discusses various trials, but also the importance of how radiation would help patients who were receiving immunotherapy-based regiments. This led to the discussion of NRG-LU002, a randomized phase II/III trial of maintenance systemic therapy vs. local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC).
He also discusses how biology affects non-small cell lung cancer (NSCLC) outcomes, the results of NRG-LU002, a randomized phase II/III trial of maintenance systemic therapy vs. local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC), and how to select patients for the optimal therapy for metastatic non-small cell lung cancer (NSCLC).
To watch the complete playlist, click here.
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Video
En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el mejor tratamiento en general.
To watch the complete playlist, click here.
Special thanks to Genentech, BMS, Takeda, Johnson & Johnson, and Daiichi-Sankyo for their sponsorship of this program.
Article
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.
Image
 (1280 x 350 px) (1280 x 250 px).png)
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Online Community
Recent Comments
The information you share is…
By LibbieRohan on
Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.
Since your doctor didn't seem too worried...